Director DENG FENG Holds 10.5M Shares in Burning Rock Biotech, Betting on Future Oncology Breakthroughs
Insider holdings at Burning Rock Biotech reveal strong confidence in its oncology platform—no immediate sales, but a sizable stake signals long‑term optimism.
3 minutes to read